Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
09
03
2021
accepted:
25
04
2021
pubmed:
2
9
2021
medline:
18
11
2021
entrez:
1
9
2021
Statut:
ppublish
Résumé
Colonic stent is recommended as a bridge to elective surgery for malignant obstruction to improve short-term clinical outcomes for patients with colorectal cancer. However, since the oncological outcomes remain controversial, this study aimed to investigate the impact of self-expandable metallic stent (SEMS) on the tumor microenvironment. Patients treated with colonic stent as a bridge to surgery from 2010 to 2015 were identified from hospital records. Tumor biopsies and resected tumor samples of the eligible patients were retrieved retrospectively. Gene expression analysis was performed using the NanoString nCounter PanCancer IO 360 gene expression panel. Of the 164 patients identified, this study included 21 who underwent colonic stent placement as a bridge to elective surgery. Gene expression analysis revealed 82 differentially expressed genes between pre- and post-intervention specimens, of which 72 were upregulated and 10 downregulated. Among the significantly upregulated genes, 46 are known to have protumor functions, of which 26 are specifically known to induce tumorigenic mechanisms such as proliferation, migration, invasion, angiogenesis, and inflammation. In addition, ten differentially expressed genes were identified that are known to promote antitumor functions. SEMS induces gene expressional changes in the tumor microenvironment that are associated with tumor progression in colorectal cancer and may potentiate a more aggressive phenotype. Future studies are warranted to establish optimal timing of surgery after SEMS insertion in patients with obstructive colorectal cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Colonic stent is recommended as a bridge to elective surgery for malignant obstruction to improve short-term clinical outcomes for patients with colorectal cancer. However, since the oncological outcomes remain controversial, this study aimed to investigate the impact of self-expandable metallic stent (SEMS) on the tumor microenvironment.
METHODS
METHODS
Patients treated with colonic stent as a bridge to surgery from 2010 to 2015 were identified from hospital records. Tumor biopsies and resected tumor samples of the eligible patients were retrieved retrospectively. Gene expression analysis was performed using the NanoString nCounter PanCancer IO 360 gene expression panel.
RESULTS
RESULTS
Of the 164 patients identified, this study included 21 who underwent colonic stent placement as a bridge to elective surgery. Gene expression analysis revealed 82 differentially expressed genes between pre- and post-intervention specimens, of which 72 were upregulated and 10 downregulated. Among the significantly upregulated genes, 46 are known to have protumor functions, of which 26 are specifically known to induce tumorigenic mechanisms such as proliferation, migration, invasion, angiogenesis, and inflammation. In addition, ten differentially expressed genes were identified that are known to promote antitumor functions.
CONCLUSION
CONCLUSIONS
SEMS induces gene expressional changes in the tumor microenvironment that are associated with tumor progression in colorectal cancer and may potentiate a more aggressive phenotype. Future studies are warranted to establish optimal timing of surgery after SEMS insertion in patients with obstructive colorectal cancer.
Identifiants
pubmed: 34467497
doi: 10.1245/s10434-021-10226-4
pii: 10.1245/s10434-021-10226-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8519-8531Informations de copyright
© 2021. Society of Surgical Oncology.
Références
Cheung DY, Lee Y, Yang CH. Status and literature review of self-expandable metallic stents for malignant colorectal obstruction. Clin Endosc. 2014;47:65–73.
pubmed: 24570885
pmcid: 3928494
Foo CC, Poon SHT, Chiu RHY, Lam WY, Cheung LC, Law WL. Is bridge to surgery stenting a safe alternative to emergency surgery in malignant colonic obstruction: a meta-analysis of randomized control trials. Surg Endosc. 2019;33:293–302.
pubmed: 30341649
Amelung FJ, Borstlap WAA, Consten ECJ, et al. Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction. Br J Surg. 2019;106:1075–86.
pubmed: 31074507
van Hooft JE, Veld JE, Arnold D, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) guideline—update 2020. Endoscopy. 2020;52:389–407.
pubmed: 32259849
Broholm M, Kobborg M, Frostberg E, et al. Delay of surgery after stent placement for resectable malignant colorectal obstruction is associated with higher risk of recurrence. Int J Colorectal Dis. 2017;32:513–6.
pubmed: 27853888
Takahashi G, Yamada T, Iwai T, et al. Oncological assessment of stent placement for obstructive colorectal cancer from circulating cell-free DNA and circulating tumor DNA dynamics. Ann Surg Onc. 2018;25:737–44.
Maruthachalam K, Las GE, Horgan EF. Tumour cell dissemination following endoscopic stent insertion. Br J Surg. 2007;94:1151–4.
pubmed: 17541987
Vymetalkova V, Cervena K, Bartu L, et al. Circulating cell-free DNA and colorectal cancer: a systematic review. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19113356 .
doi: 10.3390/ijms19113356
pubmed: 30591675
pmcid: 6337670
Spindler KG, Boysen AK, Pallisgård N, et al. Cell-free DNA in metastastic colorectal cancer: a systematic review and meta-analysis. The Oncologist. 2017;22(9):1049–55.
pubmed: 28778958
pmcid: 5599199
Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138(5):1714–26.
pubmed: 20100481
Galon J, Mlecnik B, Bindea G, et al. Towards the introduction of the “Immunoscore” in the classification of malignant tumours. J Pathol. 2014;232(2):199–209.
pubmed: 24122236
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646–74.
pubmed: 21376230
pmcid: 21376230
Tse JM, Cheng G, Tyrrell JA, et al. Mechanical compression drives cancer cells towards invasive phenotype. Proc Natl Acad Sci USA. 2012;109(3):911–6.
pubmed: 22203958
Kim BG, Gao MQ, Kang S, et al. Mechanial compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation. Cell Death Dis. 2017. https://doi.org/10.1038/cddis.2017.73 .
doi: 10.1038/cddis.2017.73
pubmed: 29233982
pmcid: 5870580
Baron TH, Harewood GC. Enteral self-expandable stents. Gastrointest Endosc. 2003;58(3):421–33.
pubmed: 14528223
Fernández-Esparrach G, Bordas JM, Giráldez MD, et al. Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer. Am J Gastroenterol. 2010;105:1087–93.
pubmed: 19935785
Veldman-Jones MH, Brant R, Rooney C, et al. Evaluating robustness and sensitivity of the nanostring technologies ncounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res. 2015;75(13):2587–93.
pubmed: 26069246
NanoString nCounter® PanCancer IO 360™ Panel. https://www.nanostring.com/products/ncounter-assays-panels/oncology/pancancer-io-360/ . Accessed 25 Jan 2021.
Nielsen PR, Eriksen JO, Lindahl LM, et al. Diagnostic two-gene classifier in early-stage mycosis fungoides: a retrospective multicenter study. J Invest Dermatol. 2021;141(1):213–7. https://doi.org/10.1016/j.jid.2020.04.026 .
doi: 10.1016/j.jid.2020.04.026
pubmed: 32454067
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289–300.
Liu TT, Liu XS, Zhang M, et al. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway. J Cancer Clin Oncol. 2018;144(6):1049–63.
Pohl S, Scott R, Arfuso F, Perumal V, Dharmarajan A. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. Tumor Biol. 2014;36:143–52.
Georgoudaki AM, Prokopec KE, Boura VF, et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 2016;15(9):2000–11.
pubmed: 27210762
Li Q, Qin Y, Wei P, et al. Gas1 Inhibits metastatic and metabolic phenotypes in colorectal carcinoma. Mol Cancer Res. 2016;14(9):830–40. https://doi.org/10.1158/1541-7786.MCR-16-0032 .
doi: 10.1158/1541-7786.MCR-16-0032
pubmed: 27401611
Wang Z, Li R, He Y, Huang S. Effects of secreted frizzled-related protein 1 on proliferation, migration, invasion, and apoptosis of colorectal cancer cells. Cancer Cell Int. 2018;18:48. https://doi.org/10.1186/s12935-018-0543-x .
doi: 10.1186/s12935-018-0543-x
pubmed: 29610564
pmcid: 5872544
Yang Z, Chen H, Huo L, et al. Epigenetic inactivation and tumor-suppressor behavior of NGFR in human colorectal cancer. Mol Cancer Res. 2015;13(1):107–19. https://doi.org/10.1158/1541-7786.MCR-13-0247 .
doi: 10.1158/1541-7786.MCR-13-0247
pubmed: 25244921
Xu Z, Zhu C, Chen C, et al. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF—a pathway in colorectal cancer. Cell Death Dis. 2018;9:974. https://doi.org/10.1038/s41419-018-1010-2 .
doi: 10.1038/s41419-018-1010-2
pubmed: 30250188
pmcid: 6155262
Murdocca M, Mango R, Pucci S, et al. The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer. Oncotarget. 2016;7(12):14765–80.
pubmed: 26895376
pmcid: 4924750
Wu XL, Lin KJ, Bai AP, et al. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World J Gastroenterol. 2014;20(30):10440–8.
pubmed: 25132760
pmcid: 4130851
Clemente N, Raineri D, Cappellano G, et al. Osteopontin bridging innate and adaptive immunity in autoimmune diseases. J Immunol Res. 2016;2016:7675437. https://doi.org/10.1155/2016/7675437 .
doi: 10.1155/2016/7675437
pubmed: 28097158
pmcid: 5206443
Olsen J, Kirkeby LT, Olsen J, et al. High interleukin-6 mRNA expression is a predicter of relapse in colon cancer. Anticancer Res. 2015;35:2235–40.
pubmed: 25862884
Waldner J, Foersch S, Neurath MF. Interleukin-6—a key regulator of colorectal cancer development. Int J Biol Sci. 2012;8:1248–53.
pubmed: 23136553
pmcid: 3491448
Wang T, Song P, Zhong T, et al. The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties. Oncogene. 2019;38:4932–47.
pubmed: 30804456
pmcid: 6756002
Vázquez-Villa F, García-Ocaña M, Galván JA, et al. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression. Tumor Biol. 2015;36:2213–22.
Luo Y, Huang K, Zheng J, Zhang J, Zhang L. TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression. Gene. 2019;688:19–25.
pubmed: 30447345
Sonvilla G, Allerstorfer S, Stättner S, et al. FGF18 in colorectal tumour cells: autocrine and paracrine effects. Carcinogenesis. 2008;29(1):15–24.
pubmed: 17890768
Zhu Z, Zhang X, Guo H, Fu L, Pan G, Sun Y. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. Mol Cell Biochem. 2015;400(1–2):287–95.
pubmed: 25476740
Zhu DJ, Chen XW, Zhang WJ, et al. Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance. Am J Cancer Res. 2015;5(6):2000–11.
pubmed: 26269759
pmcid: 4529619
Wu JI, Lin YP, Tseng CW, Chen HJ, Wang LH. Crabp2 promotes metastasis of lung cancer cells via HuR and integrin β1/FAK/ERK signaling. Sci Rep. 2019;9(1):845. https://doi.org/10.1038/s41598-018-37443-4 .
doi: 10.1038/s41598-018-37443-4
pubmed: 30696915
pmcid: 6351595
Zhou D, Bai F, Zhang X, et al. SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade. Tumor Biol. 2010;35:9935–40.
Kajiwara H, Ueno H, HashIiguchi Y, et al. Heterogeneity of metalloproteinase expression in colorectal cancer—relation of molecular findings to basic morphology. Anticancer Res. 2011;31(5):1567–75.
pubmed: 21617211
Henriksson ML, Edin S, Dahlin AM, et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am J Pathol. 2011;178(3):1387–94.
pubmed: 21356388
pmcid: 3070577
Hombach A, Rappl G, Abken H. Blocking CD30 on T cells by a dual specific CAR for CD30 and colon cancer antigens improves the CAR T cell response against CD30
pubmed: 31331813
pmcid: 6822283
Kang SA, Blache CA, Bajana S, et al. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016;16:331. https://doi.org/10.1186/s12885-016-2366-2 .
doi: 10.1186/s12885-016-2366-2
pubmed: 27220365
pmcid: 4879723
Samarendra H, Jones K, Petrinic T, et al. A meta-analysis of CXCL12 expression for cancer prognosis. Br J Cancer. 2017;117(1):124–35.
pubmed: 28535157
pmcid: 5520200
Sun D, Zhang Y, Qi Y, Zhou X, Lv G. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Cancer Epidemiol. 2015;39:135–42.
pubmed: 25677090
Liu J, Liu Z, Zhang X, Gong T, Demao Y. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. BMC Cancer. 2019;19:227. https://doi.org/10.1186/s12885-019-5406-x .
doi: 10.1186/s12885-019-5406-x
pubmed: 30866865
pmcid: 6416920
Zhanga X, Xueab J, Yangab H, Zhouc T, Zua G. TNFAIP6 promotes invasion and metastasis of gastric cancer and indicates poor prognosis of patients. Tissue Cell. 2020;68:101455. https://doi.org/10.1016/j.tice.2020.101455 .
doi: 10.1016/j.tice.2020.101455
Fang Y, Shen ZY, Zhan YZ, et al. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10:3981. https://doi.org/10.1038/s41467-019-11662-3 .
doi: 10.1038/s41467-019-11662-3
pubmed: 31484922
pmcid: 6726635
Cedzyński M, Świerzko AS. Components of the lectin pathway of complement in haematologic malignancies. Cancers (Basel). 2020;12(7):1792. https://doi.org/10.3390/cancers12071792 .
doi: 10.3390/cancers12071792
Mo M, Zhou M, Wang L, et al. CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells. PLoS ONE. 2015;10(3):e0119506. https://doi.org/10.1371/journal.pone.0119506 .
doi: 10.1371/journal.pone.0119506
pubmed: 25798926
pmcid: 4370593
Gao L, Chen X, Wang Y, Zhang J. Up-regulation of FSTL3, regulated by lncRNA DSCAM-AS1/miR-122-5p axis, promotes proliferation and migration of non-small cell lung cancer cells. Onco Targets Ther. 2020;13:2725–38.
pubmed: 32280246
pmcid: 7131999
Li JK, Yu L, Shen Y, Zhou LS, Wang YC, Zhang JH. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol. 2008;14(15):2308–13.
pubmed: 18416455
pmcid: 2705083
Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 2015;7(5):a016303. https://doi.org/10.1101/cshperspect.a016303 .
doi: 10.1101/cshperspect.a016303
pubmed: 25635046
pmcid: 4448619
Slattery ML, Sweeney C, Murtaugh M, et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis. 2005. https://doi.org/10.1093/carcin/bgi088 .
doi: 10.1093/carcin/bgi088
pubmed: 15817610
Kim SM, Kim EM, Ji KY, et al. TREM2 acts as a tumor suppressor in colorectal carcinoma through Wnt1/ β-catenin and Erk signaling. Cancers (Basel). 2019. https://doi.org/10.3390/cancers11091315 .
doi: 10.3390/cancers11091315
pubmed: 32009824
pmcid: 6948260
Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564(7735):268–72.
pubmed: 30479382
Li X, Yu W, Liang C, et al. INHBA is s prognostic predictor for patients with colon adenocarcinoma. BMC Cancer. 2020. https://doi.org/10.1186/s12885-020-06743-2 .
doi: 10.1186/s12885-020-06743-2
pubmed: 33287761
pmcid: 7720494
Chen ZL, Qin L, Peng XB, Hu Y, Liu B. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway. J Cell Physiol. 2019. https://doi.org/10.1002/jcp.28439 .
doi: 10.1002/jcp.28439
pubmed: 31808557
pmcid: 7087352
Cheng Y, Sun H, Wu L, et al. VUp-regulation of VCAN promotes the proliferation, invasion and migration and serves as a biomarker in gastric cancer. Onco Targets Ther. 2020. https://doi.org/10.2147/OTT.S262613 .
doi: 10.2147/OTT.S262613
pubmed: 33447048
pmcid: 7769148
Xu M, Liu Q, Jia Y, et al. BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma. Oncol Lett. 2016;12(4):2648–56.
pubmed: 27698837
pmcid: 5038498
Aizawa T, Karasawa H, Funayama R, et al. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer. Cancer Med. 2019;8(14):6370–82.
pubmed: 31468733
pmcid: 6797671
Yan X, Yan L, Liu S, Shan Z, Tian Y, Jin Z. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. Mol Med Rep. 2015;12(2):2999–3006.
pubmed: 25936636
Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670–3.
pubmed: 16888140
Peterson TR, Laplante M, Thoreen CC, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 2009;137(5):873–86.
pubmed: 19446321
pmcid: 2758791
Iida Y, Sunami E, Yamashita H, et al. Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasis. Anticancer Res. 2015;35(3):1459–64.
pubmed: 25750298
Qiu Z, Li Y, Zeng B, et al. Downregulated CDKN1C/p57
pubmed: 29428729
Lin SC, Hsioa KY, Chang N, Hou PC, Tsai SJ. Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer. J Pathol. 2017;241(5):638–48.
pubmed: 28026024
Li Y, Chen Y, Mioa L, et al. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells. Cancer Lett. 2021;497:212–20.
pubmed: 33132120
Huang Y, Li G, Wang K, et al. Collagen type VI alpha 3 chain promotes epithelial-mesenchymal transition in bladder cancer cells via transforming growth factor β (TGF-β)/Smad pathway. Med Sci Monit. 2018;24:5346–54.
pubmed: 30066698
pmcid: 6085978
Ma SS, Srivastava S, Llamosas E, et al. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. BMC Cancer. 2016. https://doi.org/10.1186/s12885-016-2576-7 .
doi: 10.1186/s12885-016-2576-7
pubmed: 27899080
pmcid: 5129646
Kim J, Kang HS, Lee YJ, et al. EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Cancer Lett. 2014;349(1):35–44.
pubmed: 24704156
Zhang Y, Zhang LX, Liu XQ, et al. Id4 promotes cell proliferation in hepatocellular carcinoma. Chin J Cancer. 2017. https://doi.org/10.1186/s40880-017-0186-7 .
doi: 10.1186/s40880-017-0186-7
pubmed: 29284539
pmcid: 5747160
Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin Cancer Res. 2004. https://doi.org/10.1158/1078-0432.CCR-04-0689 .
doi: 10.1158/1078-0432.CCR-04-0689
pubmed: 15569977
Liang L, Zeng JH, Qin XG, Chen JQ, Luo DZ, Chen G. Distinguishable prognostic signatures of left- and right-sided colon cancer: a study based on sequencing data. Cell Physiol Biochem. 2018;48(2):475–90.
pubmed: 30016783
Huang X, Pan Y, Ma J, et al. Prognostic significance of the infiltration of CD163
pubmed: 29573574
pmcid: 5943426
Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem. 2004;279(25):26707–15.
pubmed: 15084607
Zhu M, Xu W, Wei C, et al. CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis. Cell Death Dis. 2019. https://doi.org/10.1038/s41419-019-1966-6 .
doi: 10.1038/s41419-019-1966-6
pubmed: 31831728
pmcid: 6908646
Ge H, Mu L, Jin L, et al. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. Int J Cancer. 2017;144(7):1434–44.
Göke F, Göke A, von Mässenhausen A, et al. Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer. Digestion. 2013;88(3):172–81.
pubmed: 24135816
Huynh PT, Beswick EJ, Coronado YA, et al. CD90
pubmed: 26595254
Wu B, Tao L, Yang D, et al. Development of an immune infiltration-related eight-gene prognostic signature in colorectal cancer microenvironment. Biomed Res Int. 2020. https://doi.org/10.1155/2020/2719739 .
doi: 10.1155/2020/2719739
pubmed: 33490257
pmcid: 7785366
Wu ZY, Wei Z, Sun SJ, et al. Activating transcription factor 3 promotes colon cancer metastasis. Tumor Biol. 2014;33:8329–34.
Tacconi C, Ungaro F, Correale C, et al. Activation of the VEGFC/VEGFR3 pathway induces tumor immune escape in colorectal cancer. Cancer Res. 2019. https://doi.org/10.1158/0008-5472.CAN-18-3657 .
doi: 10.1158/0008-5472.CAN-18-3657
pubmed: 31239267
Crivello P, Ahci M, Maaßen F, et al. Multiple knockout of classical HLA class II β-chains by CRISPR/Cas9 genome editing driven by a single guide RNA. J Immunol. 2019;202(6):1895–903.
pubmed: 30700588
Zhang D, Bi J, Liang Q, et al. VCAM1 promotes tumor cell invasion and metastasis by inducing EMT and transendothelial migration in colorectal cancer. Front Oncol. 2020. https://doi.org/10.3389/fonc.2020.01066 .
doi: 10.3389/fonc.2020.01066
pubmed: 33928019
pmcid: 7787160
Cui G, Yuan A, Pang Z, et al. Contribution of IL-33 to the pathogenesis of colorectal cancer. Front Oncol. 2018. https://doi.org/10.3389/fonc.2018.00561 .
doi: 10.3389/fonc.2018.00561
pubmed: 30619732
pmcid: 6296341
Basit F, Mathan T, Sancho D, de Vries IJ. Human dendritic cell subsets undergo distinct metabolic reprogramming for immune response. Front Immunol. 2018. https://doi.org/10.3389/fimmu.2018.02489 .
doi: 10.3389/fimmu.2018.02489
pubmed: 30455688
pmcid: 6230993
Edin S, Kaprio T, Hagström J, et al. The prognostic importance of CD20
doi: 10.1038/s41598-019-56441-8
pubmed: 31882709
pmcid: 6934737
Yang D, Li Q, Shang R, et al. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway. J Exp Clin Cancer Res. 2020. https://doi.org/10.1186/s13046-020-01774-w .
doi: 10.1186/s13046-020-01774-w
pubmed: 33317572
pmcid: 7737286
Mammadova-Bach E, Rupp T, Spenlé C, et al. Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma. Biol Cell. 2018;110(8):178–95.
Zhu J, Ghosh A, Sarkar SN. OASL—a new player in controlling antiviral innate immunity. Curr Opin Virol. 2015;12:15–9.
pubmed: 25676874
pmcid: 4470762
Ning Y, Labonte MJ, Zhang W, et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2020;11(6):1353–64.
Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal. 2009. https://doi.org/10.1621/nrs.07003 .
doi: 10.1621/nrs.07003
pubmed: 19381306
pmcid: 2670432
Mar AC, Chu CH, Lee HJ, et al. Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis. J Biol Chem. 2015;290(36):22212–24.
pubmed: 26209639
pmcid: 4571972
Nfonsam VN, Nfonsam LE, Chen D, et al. COMP gene coexpresses with EMT genes and is associated with poor survival in colon cancer patients. J Surg Res. 2018;233:297–303.
pubmed: 30502262
Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallells between normal development and tumor progression. J Mammary Gland Biol. 2010;15:117–34.
Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995;154:8–20.
pubmed: 8714286
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99.
pubmed: 20303878
pmcid: 2866629
Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms and consequences. Immunity. 2019;51:27–41.
pubmed: 31315034
pmcid: 6831096
Elmore S. Apoptosis: a review of programmed cell death. Toxical Pathol. 2007. https://doi.org/10.1080/01926230701320337 .
doi: 10.1080/01926230701320337
Yu X, Wang D, Wang X, et al. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. J Exp Clin Cancer Res. 2019. https://doi.org/10.1186/s13046-018-1014-x .
doi: 10.1186/s13046-018-1014-x
pubmed: 31852504
pmcid: 6921559
Li X, Xiang Y, Li F, Yin C, Li B, Ke X. WNT/β-catnin signaling pathway regulating T cell-inflammation in the tumor microenvironment. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.02293 .
doi: 10.3389/fimmu.2019.02293
pubmed: 32117215
pmcid: 6933613
He S, Huang S, Shen Z. Biomarkers for the detection of necroptosis. Cell Mol Life Sci. 2016;73:2177–81.
pubmed: 27066893
Merrick WC, Pavitt GD. Protein synthesis initiation in eukaryotic cells. Cold Spring Harb Perspect Biol. 2018;10:a033092.
pubmed: 29735639
pmcid: 6280705
Sissy CE, Kirilovsky A, Van den Eynde M, et al. A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy. Clin Cancer Res. 2020;26(19):5198–207.
pubmed: 32669377
Anitei MG, Zeitoun G, Mlecnik B, et al. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res. 2014;20(7):1891–9.
pubmed: 24691640
Matsutani S, Shibutani M, Maeda K, et al. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer. Cancer Sci. 2018;109(4):966–79.
pubmed: 29464828
pmcid: 5891199
Yasuda K, Nirei T, Sunami E, Nagawa H, Kitayama J. Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol. 2011. https://doi.org/10.1186/1748-717X-6-49 .
doi: 10.1186/1748-717X-6-49
pubmed: 21575175
pmcid: 3120676